Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank86
Studio
Year-over-Year Change

Free cash flow yield

Latest
-0.65%
↑ 88% vs avg
Percentile
P86
Within normal range
Streak
2 yr
Consecutive growthElevated
Average
-5.41%
Historical baseline
PeriodValueYoY Change
2025-0.65%+83.9%
2024-4.06%+80.3%
2023-20.67%-50.6%
2022-13.72%-2107.3%
20210.68%+126.6%
2020-2.57%-168.2%
2019-0.96%+29.0%
2018-1.35%-